Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats

Adriamycin (ADR) is a chemotherapeutic drug used to treat tumors in a clinical setting. However, its use is limited by a side effect of cardiotoxicity. Glibenclamide (Gli), an inhibitor of mitochondrial ATP-dependent potassium (K-ATP) channels, blocks the cardioprotective effects of mitochondrial K-...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Meng-Lin, Wang, Meng-Long, Lv, Jing-Jun, Wei, Jie, Wan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840948/
https://www.ncbi.nlm.nih.gov/pubmed/29545864
http://dx.doi.org/10.3892/etm.2018.5862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840948/
https://www.ncbi.nlm.nih.gov/pubmed/29545864
http://dx.doi.org/10.3892/etm.2018.5862

Ejemplares similares